Therapeuticsmd Inc
(TXMD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2006 | |
| Sales | 15,026 | 8,776 | 3,818 | 2,088 | 0 |
| Cost of Goods | 3,672 | 1,960 | 1,348 | 947 | N/A |
| Gross Profit | 11,354 | 6,816 | 2,470 | 1,141 | N/A |
| Operating Expenses | 66,067 | 33,584 | 18,966 | 7,515 | 0 |
| Operating Income | -54,041 | -25,808 | -16,148 | -5,427 | N/A |
| Interest Expense | 0 | 1,166 | 1,905 | 64 | 0 |
| Other Income | -176 | -1,445 | -17,066 | -7,422 | 0 |
| Pre-tax Income | -54,217 | -28,419 | -35,120 | -12,913 | 0 |
| Net Income Continuous | -54,217 | -28,419 | -35,120 | -12,913 | N/A |
| Net Income | $-54,217 | $-28,419 | $-35,120 | $-12,913 | $N/A |
| EPS Basic Total Ops | -18.00 | -11.00 | -19.00 | -10.50 | N/A |
| EPS Basic Continuous Ops | -18.11 | -11.14 | -19.16 | -10.33 | N/A |
| EPS Diluted Total Ops | -18.00 | -11.00 | -19.00 | -10.50 | N/A |
| EPS Diluted Continuous Ops | -18.11 | -11.14 | -19.16 | -10.33 | N/A |
| EBITDA(a) | $-53,729 | $-23,196 | $-14,488 | $-5,318 | $N/A |